ArticleCancer research2019

HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer.

Takeshi Fukumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.